Expert Care, Close To Home.


APU Direct   
320.259.1411
888.559.1411

Prostate Cancer


 

  • Single Arm, Prostate Cryoablation Registry to Prospectively Determine the Long Term Efficacy and Morbidity of Patients who Undergo Cryoablation as a Treatment for Prostate Cancer
  • An Open label, Single Arm, Extension Study to Evaluate the Long Term Safety of XXX in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
  • Phase III, randomized, double-blind, placebo-controlled study to evaluate XXX in the treatment of bone loss in subjects undergoing Androgen-Deprivation Therapy for non-metastatic prostate cancer
  • Cancer of the prostate strategic urologic research endeavor (CaPSURE™) a longitudinal observational study of prostate cancer patients nationwide
  • An eight-month, open-labeled, fixed-dose study to evaluate the safety, tolerance, pharmacokinetics and endocrine efficacy of two doses of a medication in patients with prostate cancer

 

APU CONNECT      EMPLOYMENT       WEBSITE DISCLAIMER     © 1998–2011 APUMN.COM. All RIGHTS RESERVED.  Powered by LiveEdit™


Main Office
2351 Connecticut Ave South
Suite 200
Sartell, MN 56377
Tel: 320.259.1411
Fax: 320.259.8967
Toll-free: 888.559.1411
[ map ]


Buffalo Office
1700 Highway 25 North
Suite 120
Buffalo, MN 55313
Tel: 763.682.2268
[ map ]


Research Office
320.229.4547

(and 14 outreach clinics)


 
 





257.jpg